There were no significant differences in age, sex, background of liver disease, Child‒Pugh grade, BCLC stage, serum ALB concentration, total bilirubin (TBIL) level, number of tumours, tumour thrombosis, or tumour differentiation between the two groups. This evidence concerns the gene ALB and neoplasm.